Search clinical trials for: generalization

Total 43 results

Fondation Ophtalmologique Adolphe de Rothschild

Not yet recruiting

Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial. (IMCOMG)

Ocular Myasthenia Gravis
Ruhr University of Bochum

Not yet recruiting

The Effect of Time on Generalization of Exposure-based Benefit

One Week Follow-up Assessment | Six Weeks Follow-up Assessment | Three Months Follow-up Assessment

Germany
Virginia Commonwealth University

Not yet recruiting

Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation

Cerebellum | Motor Adaptation and Generalization | Posterior Parietal Cortex
University of Delaware
National Institute on Aging (NIA)

Recruiting

Effects of Acute Pain vs Context Change on Motor Learning Retention in Young Adults

Pain, Acute | Motor Activity

United States
Stanford University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Interventions in Mathematics and Cognitive Skills

Cognitive Dysfunction | Cognitive Change | Learning Disabilities | Individuality | Child Development | Developmental Disability | Behavior | Cognition | Learning Curve | Decision Making | Behavior and Behavior Mechanisms | Behavior, Child | Cognitive Impairment, Mild | Cognition Disorder | Neuroscience | Cognitive Orientation and other conditions

United States
Diamyd Medical AB

Recruiting

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

Type 1 Diabetes Mellitus

Czechia, Spain, United States, Hungary, Netherlands, Estonia, Germany, Poland, Sweden
KU Leuven
RIZIV

Recruiting

Predictors of Work Resumption After Back Surgery (WABS)

Low Back Pain

Belgium
University of North Carolina, Chapel Hill
Focused Ultrasound Foundation

Recruiting

A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy

Partial Seizures With Secondary Generalization

United States
Cerebral Therapeutics LLC

Terminated

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

Refractory Epilepsy

Israel, Australia
National Cheng-Kung University Hospital
Ministry of Science and Technology, Taiwan

Completed

Short-term Postural Training for Older Adults (P)

Aging | Balance

Taiwan
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

Epilepsy | Partial Seizures With or Without Secondary Generalization

China, Japan, Malaysia, Philippines, Singapore, Taiwan, Thailand
Eisai Inc.

Completed

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

Partial Onset Seizures

Germany, Sweden, Norway, Austria, Denmark
UCB Biopharma SRL

Enrolling by invitation

A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Epilepsy | Partial Seizures With or Without Secondary Generalization

China, Japan
Ruhr University of Bochum

Completed

Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure

Fear of Spiders | Fear of Heights

Germany
Ohio Northern University
National Institute of Mental Health (NIMH)

Completed

Stress, Sex, and the Generalization of Fear

Psychological Stress

United States
University of Minnesota

Withdrawn

TDCS-potentiated Generalization of Cognitive Training in the Rehabilitation of Long COVID Symptoms

Post-acute Sequelae SARS-CoV-2 Infection (PASC)

United States
Eisai Limited

Completed

A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Idiopathic Generalized Epilepsy | Partial Onset Seizures | Generalised Tonic-Clonic Seizures

France, Spain, Italy, Denmark, Germany, Portugal, Russian Federation
María Rodríguez Bailón
Universidad de Granada

Completed

An Executive/Monitoring Treatment Protocol on Everyday Life Activities

Executive Dysfunction | Anosognosia | Brain Damage

Spain
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
University of Illinois at Chicago
National Institute on Aging (NIA)

Active, not recruiting

Effect of Adaptive Training for Balance Recovery

Balance, Postural | Prevention, Accident

United States
UCB Biopharma S.P.R.L.

Completed

A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Epilepsy | Partial Seizures With or Without Secondary Generalization

Japan
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Ocular Mysathenia Gravis Generalization (MYASTEN)

Ocular Myasthenia Gravis

France
Eisai Korea Inc.

Completed

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

Epilepsy

Korea, Republic of
UCB Japan Co. Ltd.

Completed

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

Japan
University of California, Los Angeles

Completed

Generalization of Extinction Learning

Social Anxiety Disorder

United States
Eisai GmbH

Completed

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Focal Epilepsy

Germany
Ruhr University of Bochum

Completed

Effects of Stress on Exposure Therapy

Specific Phobia

Germany
Butler Hospital

Withdrawn

Modulating Context Generalization Through Transcranial Direct Current Stimulation

Anxiety and Fear

United States
Valexfarm

Completed

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Epilepsy | Complex Partial Seizures | Simple Partial Seizures | Partial Seizures With Secondary Generalization

Russian Federation
University of Minnesota

Completed

The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls. (DCS)

Post Traumatic Stress Syndrome

United States
Ruhr University of Bochum

Completed

Extinction Generalization in Exposure Therapy

Specific Phobia
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

Epilepsy | Partial Seizures
Hospices Civils de Lyon

Unknown

Impact of Stress Management Training After Cardiac Transplantation (QUIET)

Heart Transplant

France
University Hospital Schleswig-Holstein

Completed

Lacosamid-i.v.-Register (LCM)

Epilepsy With Partial Onset Seizures With or Without Secondary Generalization

Germany
San Diego State University
National Institute of Mental Health (NIMH); Oregon Social Learning Center

Completed

Community Implementation of KEEP: Fidelity and Generalization of Parenting (KEEP)

Behavior Problems

United States
UCB Pharma

Completed

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Epilepsies, Partial

United States
UCB Pharma

Completed

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Partial Seizures With or Without Secondary Generalization

Germany
UCB Pharma

Completed

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Epilepsy
Eisai GmbH

Terminated

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Epilepsy

Germany
Tongji University

Completed

Application and Generalization of Flutter Mucus Clearance Device

Pulmonary Disease, Chronic Obstructive

China
Shalvata Mental Health Center
Weizmann Institute of Science

Unknown

Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders

PTSD | Bipolar Disorder | MDD | Schizophrenia Disorder | Anxiety Disorder (Panic Disorder or GAD)

Israel
US Department of Veterans Affairs

Completed

Generalization of Training in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States

Search clinical trials for: generalization

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations